Evidence map›Paper›PMID 35202193›Full record

Trial reportTomography (Ann Arbor, Mich.)2022

AI-Radiomics Can Improve Inclusion Criteria and Clinical Trial Performance.

Michal R Tomaszewski, Shuxuan Fan, Alberto Garcia, Jin Qi, Youngchul Kim, Robert A Gatenby, Matthew B Schabath, William D Tap, Denise K Reinke, Rikesh J Makanji and 2 more

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Tomography (Ann Arbor, Mich.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  4. Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  5. Radiomic-Based Approaches in the Multi-metastatic Setting: A Quantitative Review.medRxiv : the preprint server for health sciences · 2024
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Michal R TomaszewskiDepartment of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-3194-9492
Shuxuan FanDepartment of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Alberto GarciaDepartment of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Jin QiDepartment of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Youngchul KimDepartment of Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Robert A GatenbyDepartment of Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Matthew B SchabathDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0003-3241-3216
William D TapDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Denise K ReinkeSarcoma Alliance for Research through Collaboration, Ann Arbor, MI 48106, USA.
Rikesh J MakanjiDepartment of Radiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-0115-2765
Damon R ReedSarcoma Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Robert J GilliesDepartment of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-8888-7747
Moffitt Cancer Center · USMemorial Sloan Kettering Cancer Center · USSarcoma Alliance for Research through Collaboration · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"U54CA193489 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, GATENBY, ROBERT A · 2015 to 2020
$12.5M
Radiomics of NSCLCU01CA143062 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GILLIES, ROBERT J., SCHABATH, MATTHEW B. · 2010 to 2020
$5.7M
Imaging Habitats in SarcomaR01CA187532 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GILLIES, ROBERT J., MARTINEZ, GARY · 2015 to 2019
$2.7M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA187532NCI NIH HHS U01 CA143062NCI NIH HHS U54 CA193489
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SarcomaSoft Tissue NeoplasmsArtificial IntelligenceDoxorubicinHumansRetrospective StudiesDoxorubicindoxorubicinenrichment strategyevofosfamideradiomicssarcomatrial design

Identifiers

PMID35202193
PMCPMC8880510
OpenAlexW4210572360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.